Immunocore raises $258.3m for IPO
UK-based Immunocore, a biotech company, has raised about $258.3 million for its IPO after pricing its over 9.93 million shares at $26 per share.
UK-based Immunocore, a biotech company, has raised about $258.3 million for its IPO after pricing its over 9.93 million shares at $26 per share.
Copyright PEI Media
Not for publication, email or dissemination